Yesterday, J.C. Penney (NYSE: JCP ) made a preliminary announcement regarding its first-quarter results for the quarter ended May 4, 2013. The announcement was made in conjunction with its earlier news that the company had secured a $1.75 billion credit facility. The good news is that the company is still a company, having successfully stayed afloat for one more year. The bad news is just about everything else.
Making all the right choices
J.C. Penney said that it was looking for a 16.4% fall in revenue for the first quarter. It's also expecting a 16.6% decline in comparable sales, due to ongoing construction work in 505 stores across the U.S. Finally, the company has managed to burn through $80 million of cash in the three months since the end of its last fiscal year. In short, J.C. Penney has continued to be J.C. Penney.
On the bright side, this could be a turning point. Maybe CEO Mike Ullman can manage to stop the company's seemingly inevitable decline into liquidation. While customers are clearly still uninterested in shopping at J.C. Penney, Ullman has been with the company long enough to know what could bring people back to the fold.
Top Electric Utility Companies To Own In Right Now: Beazer Homes USA Inc. (BZH)
Beazer Homes USA, Inc. designs, builds, and sells single-family and multi-family homes. The company offers homes for entry-level, move-up, or retirement-oriented buyers. It also engages in rental of previously owned homes that are purchased and improved by the company. The company sells its homes through commissioned new home sales counselors and independent brokers. It operates in 16 states, including Arizona, California, Delaware, Florida, Georgia, Indiana, Maryland, Nevada, New Jersey, New York, North Carolina, Pennsylvania, South Carolina, Tennessee, Texas, and Virginia. Beazer Homes USA, Inc. was founded in 1985 and is headquartered in Atlanta, Georgia.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM] Records fell on Wall Street Friday as another solid report on housing lifted the market for the second day in a row. There's a three-day weekend coming up -- something that often prompts investor caution -- but the gains were broad-based even though volume was fairly light. The VIX, which measures volatility, fell to its lowest level this year. The Dow Jones industrial average (^DJI) gained 63 points, the Nasdaq composite (^IXIC) rose 31, and the Standard & Poor's 500 index (^GPSC) added 8, topping the record high set last week. The Dow Transportation average also raced to an all-time high, lifted by airline stocks. United (UAL) soared more than 4 percent; Delta (DAL) gained more than 1 percent and Southwest (LUV) gained 2 percent. Southwest is at an all-time high, up 79 percent from a year ago. New home sales bounced back with a better than expected 6.4 percent increase last month. Lennar (LEN) and D.R. Horton (DHI) both rose 4 percent. Pulte (PHM), Beazer (BZH) and Hovnanian (HOV) also solid posted gains. Earnings continue to drive retail stocks. Gap (GPS) edged higher even though net fell. Foot Locker (FL) gained 1½ percent after topping expectations. GameStop (GME) rose 4 percent. Its net rose, helped by the rollout last year of new Xbox and PlayStation consoles. Zumiez (ZUMZ) rose 5½ percent on an earnings beat. But Aeropostale (ARO) tumbled 24 percent. Its loss widened and sales declined. The retailer continues to struggle with teen fashion trends. Also on the earnings front, TiVo (TIVO) rose 2 percent as it swung to a profit from a year ago loss. It also reported an increase in the number of subscribers. Hewlett-Packard (HPQ) rose 6 percent on news the company plans to eliminate up to 16,000 additional workers in an effort to cut costs. And several stocks extended big moves from yesterday. Best Buy (BBY) rose more than 3 percent for the second straight day after earnings beat expectations. Isis Pharmaceuticals (ISIS) jumped
- [By Federico Zaldua]
Beazer Homes USA (BZH), the diversified home-builder which is held by Mario Gabelli from GAMCO Investors, is my top play among single-family and multi-family home builders. While I believe higher interest rates should slow the pace of margin expansion for Beazer, I also believe higher top line growth will more than compensate interest rate effects on net earnings. As a matter of fact, I think gross margins are going to go north of 17.5% by the end of 2014 while top-line should keep on growing at a rate of 25%.
Top 10 Diversified Bank Stocks To Own For 2014: RDA Microelectronics Inc.(RDA)
RDA Microelectronics, Inc., a fabless semiconductor company, designs, develops, and markets radio-frequency and mixed-signal semiconductors for cellular, broadcast, and connectivity applications. Its products include power amplifiers, transceivers and front-end modules, FM radio receivers and transmitters, set-top box tuners, analog mobile television receivers, walkie-talkie transceivers, LNB satellite downconverters, and Bluetooth system-on-chips for mobile handsets. The company?s products also comprise GSM/EDGE power amplifier modules, GSM transceivers, TD-SCDMA transceivers, SCDMA transceivers, 3G switch modules, GSM power amplifier and switch modules, PHS transceivers, TD-SCDMA/GSM dual-mode transceivers, and radio frequency switches; DVB-T tuners, DVB-S and DVB-S2 satellite tuners, analog mobile television receiver system-on-chips, and FM radio receivers with radio data system; and Bluetooth + FM system-on-chips for mobile handsets and walkie-talkie transceivers for professional applications. Its products are incorporated into mobile handsets, set-top boxes, MP3 players, and other wireless and consumer electronic devices. RDA Microelectronics sells its products through distributors in the People?s Republic of China, southeast Asia, India, the Middle East, Africa, the Russian Federation, and Latin America. The company was founded in 2004 and is headquartered in Shanghai, the People?s Republic of China.
Advisors' Opinion:- [By Jake L'Ecuyer]
RDA Microelectronics (NASDAQ: RDA) was also up, gaining 11.12 percent to $17.28 after the company announced the receipt of $18.00/ADS acquisition proposal from Tsinghua Unigroup.
Top 10 Diversified Bank Stocks To Own For 2014: Sunoco Logistics Partners LP (SXL)
Sunoco Logistics Partners L.P. engages in the transport, terminalling, and storage of refined products and crude oil, as well as the purchase and sale of crude oil in the United States. Its Refined Products Pipeline System segment owns and operates approximately 2,200 miles of refined product pipelines that transport gasoline, heating oil, diesel and jet fuel, and liquefied petroleum gas (LPG). This segment also includes approximately 100-mile refined products Harbor pipeline, and 50 miles of inter refinery pipelines; and various joint venture interests in refined product pipeline companies. The company?s Terminal Facilities segment consists of 42 refined product terminals with an aggregate storage capacity of 7.2 million barrels, primarily serving the Refined Products Pipeline System; the Nederland Terminal, a 20.2 million barrel marine crude oil terminal on the Texas Gulf Coast; a 2.0 million barrel refined products terminal serving Sunoco?s Marcus Hook refinery near Phi ladelphia, Pennsylvania; 1 inland and 2 marine crude oil terminals with a combined capacity of 3.4 million barrels, and related pipelines that serve Sunoco?s Philadelphia refinery; and a 1.0 million barrel LPG terminal near Detroit, Michigan. Its Crude Oil Pipeline System segment gathers, purchases, sells, and transports crude oil principally in Oklahoma and Texas. This segment consists of approximately 4,900 miles of crude oil trunk pipelines; approximately 500 miles of crude oil gathering lines; approximately 110 crude oil transport trucks; and approximately 100 crude oil truck unloading facilities. This segment also holds a 91% interest in the Mid-Valley Pipeline Company that owns approximately 1,000 miles of crude oil pipelines; a 60.3% interest in West Texas Gulf Pipe Line Company, which includes approximately 600 miles of crude oil pipe; and a 37.0 percent undivided interest in the 100-mile Mesa Pipe Line system. The company was founded in 2001 and is based in Philadel phia, Pennsylvania.
Advisors' Opinion:- [By Matt DiLallo]
The potential bidders
There are a lot of names being thrown around as potential purchasers of these assets, including Marathon Petroleum (NYSE: MPC ) , Sunoco Logistics (NYSE: SXL ) , and Buckeye Partners (NYSE: BPL ) . Both Sunoco and Buckeye are MLPs, which is where I personally think these assets are best suited. Let's take a closer look at each company to see which one makes the most strategic sense. - [By Arie Goren]
After running this screen on May 21, 2013, before the markets' open, I discovered the following eight stocks: Sunoco Logistics Partners LP (SXL), Leggett & Platt Inc (LEG), Copa Holdings SA (CPA), RPC Inc. (RES), Tupperware Brands Corp. (TUP), Herbalife Ltd. (HLF), John Wiley & Sons Inc. (JW.A) and C.H. Robinson Worldwide Inc. (CHRW).
- [By Arjun Sreekumar]
Additionally, new and reversed pipelines are allowing more crude oil to flow directly from oil and gas hot spots, such as the Permian Basin of West Texas, to Gulf Coast refineries. For instance, Magellan Midstream Partners' (NYSE: MMP ) started up its reversed Longhorn pipeline in April, which provided another 225,000 barrels per day of incremental capacity from West Texas to Houston-area refineries, while Sunoco Logistics Partners (NYSE: SXL ) is expected to start up its Permian Express project this month, which will provide additional capacity out of the Permian Basin of about 90,000 barrels per day.
- [By Marc Bastow]
Crude oil and refined petroleum products logistics company Sunoco Logistics Partners (SXL) raised its quarterly dividend 5.2% to 66.25 cents per share, payable on Feb. 14 to shareholders of record as of Feb. 10.
SXL Dividend Yield: 3.40%
Top 10 Diversified Bank Stocks To Own For 2014: Warner Chilcott plc(WCRX)
Warner Chilcott Public Limited Company, a specialty pharmaceutical company, together with its subsidiaries, engages in the development, manufacture, and promotion of branded pharmaceutical products focusing on the women?s healthcare, gastroenterology, dermatology, and urology markets in North America and western Europe. Its principal products include ACTONEL for the prevention and treatment of postmenopausal osteoporosis; ATELVIA for the treatment of postmenopausal osteoporosis; LOESTRIN 24 FE and LO LOESTRIN FE, which are oral contraceptives for the prevention of pregnancy; ESTRACE cream, a vaginal cream for the treatment of vaginal and vulvar atrophy; ASACOL for the treatment of ulcerative colitis for orally administered 5-aminosalicylic acid products and maintenance of remission; ASACOL HD for the treatment of moderately active ulcerative colitis; DORYX, a tetracycline-class oral antibiotic for the treatment of severe acne; and ENABLEX for the treatment of overactive b ladder. The company markets its products and services through wholesale pharmaceutical distributors, and retail drug store chains. It has a strategic collaboration agreement with Sanofi-Aventis U.S. LLC. Warner Chilcott Public Limited Company was founded in 1968 and is headquartered in Dublin, Ireland.
Advisors' Opinion:- [By Rich Smith]
On Friday, shares of branded pharmaceutical manufacturer Warner Chilcott (NASDAQ: WCRX ) jumped 20% in response to rumors that the company was in talks to sell itself to larger rival Actavis (NYSE: ACT ) . Warner also reported steady earnings, where a decline had been expected, and reiterated full-year guidance.
- [By Sean Williams]
What: Shares of Warner Chilcott (NASDAQ: WCRX ) , a branded pharmaceutical company focused on women's health care, shot higher by as much as 20% after the company reported its first-quarter earnings results, and on news that it could be a buyout target.
- [By Dan Caplinger]
Tomorrow, Warner Chilcott (NASDAQ: WCRX ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed kneejerk reaction to news that turns out to be exactly the wrong move.
Top 10 Diversified Bank Stocks To Own For 2014: Synovus Financial Corp.(SNV)
Synovus Financial Corp., a diversified financial services and bank holding company, provides commercial and retail banking, financial management, insurance, and mortgage services in Georgia, Alabama, South Carolina, Florida, and Tennessee. Its retail banking services include accepting customary types of demand and savings deposits; mortgage, installment, and other retail loans; investment and brokerage services; safe deposit services; automated banking services; automated fund transfers; Internet based banking services; and bank credit card services, including mastercard and visa services. The company?s commercial banking services comprise cash management and asset management services, capital markets services, and institutional trust services, as well as commercial, financial, and real estate loans. It also provides various other financial services, which include the portfolio management for fixed-income securities, investment banking, the execution of securities transac tions as a broker/dealer, and the provision of individual investment advice on equity and other securities; trust services; mortgage services; and financial planning services. Synovus Financial Corp. was founded in 1888 and is headquartered in Columbus, Georgia.
Advisors' Opinion:- [By Robert Eberhard]
Much-maligned regional bank Synovus Financial (NYSE: SNV ) reported first-quarter earnings this morning, and it pretty much went as expected. With consensus estimates pegging the Georgia bank at $0.02 earnings per share, Synovus didn't disappoint and met that number, and the stock has risen in trading today.
Top 10 Diversified Bank Stocks To Own For 2014: Fibria Celulose SA (FBR)
Fibria Celulose S.A. (Fibria), formerly Votorantim Celulose e Papel S.A., incorporated on July 25, 1941, is a producer of market pulp. During the year ended December 31, 2010, Fibria produced 5,054 kilotons of eucalyptus pulp (including 50.0% of the pulp production of Veracel). The Company also produces coated and uncoated paper, carbonless paper and thermal paper at its Piracicaba paper mill, located in the State of Sao Paulo with an annual production capacity of 190 kilotons. During 2010, it produced 115 kilotons of paper products and recorded consolidated net revenues. Fibria produces bleached eucalyptus kraft pulp at three pulp mills, the Aracruz pulp mill located in the State of Espirito Santo, which has an annual production capacity of 2.3 million tons; the Tres Lagoas pulp mill located in the State of Mato Grosso do Sul, which has an annual production capacity of 1.3 million tons, and the Jacarei pulp mill located in the State of Sao Paulo, which has an annual production capacity of 1.1 million tons. The Company has a 50% interest in Veracel, which owns and operates a pulp mill in the municipality of Eunapolis, State of Bahia, with an annual production capacity of 1.1 million tons.
Pulp
Fibria produces bleached eucalyptus kraft pulp from planted eucalyptus trees. Bleached eucalyptus kraft pulp is a range of hardwood pulp. Eucalyptus is a hardwood tree, and its pulp has short fibers and is generally suited to manufacturing tissue, coated and uncoated printing and writing paper and coated packaging boards. Short fibers are optimal for manufacturing wood-free paper with good printability, smoothness, brightness and uniformity. Market pulp is the pulp sold to producers of paper products. Kraft pulp is pulp produced in a chemical process using sulphate. During 2010, it produced 5,054 kilotons of pulp (including 50.0% of the pulp production of Veracel).
Paper
During 2010, Fibria produced 115 kilotons of paper. The Company produced coated printing an! d writing paper, which is a coated woodfree paper used for promotional materials, folders, internal sheets and cover of magazines, books, tabloids, inserts and mailing; uncoated printing and writing paper, which is a uncoated woodfree paper in reels and sheets; carbonless paper, which is used to produce multi-copy forms, POS, invoices and other applications in place of traditional carbon paper, and thermal paper, which is traditionally used in fax machines; POS, bar code labels, toll tickets, water and gas bills and receipts for automated teller machines (ATMs) and credit card machines. It manufactures thermal paper products with technology licensed byOji Paper Co., Ltd (Oji Paper).
The Company competes with APRIL, Arauco, APP, Georgia Pacific, CMPC, Sodra, Stora Enso, Weyerhaeuser and Suzano.
Advisors' Opinion:- [By Seth Jayson]
Fibria Celulose (NYSE: FBR ) reported earnings on July 24. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), Fibria Celulose met expectations on revenues and missed expectations on earnings per share.
Top 10 Diversified Bank Stocks To Own For 2014: Orexigen Therapeutics Inc.(OREX)
Orexigen Therapeutics, Inc., a development stage company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed phase III clinical trials; and Empatic that has completed phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; and naltrexone is a treatment for alcohol and opioid addiction. The company?s Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide is for the adjunctive treatment of partial seizures, a form of epilepsy. The company has a collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Contrave. Orexigen Therapeutics, Inc. was founded in 2002 and is based in La Jolla, California.
Advisors' Opinion:- [By Jake L'Ecuyer]
Shares of Orexigen Therapeutics (NASDAQ: OREX) got a boost, shooting up 9.64 percent to $6.23 after the company announced successful results of the interim analysis of the Light Study.
- [By Monica Gerson]
Orexigen Therapeutics (NASDAQ: OREX) is estimated to post a Q4 loss at $0.19 per share on revenue of $900.00 thousand.
Delcath Systems (NASDAQ: DCTH) is expected to post a Q4 loss at $0.05 per share on revenue of $100.00 thousand.
- [By Brian Orelli]
VIVUS' direct competitors in the obesity space both have large partners. Arena Pharmaceuticals (NASDAQ: ARNA ) secured a marketing deal with Eisai to market Belviq, and Orexigen (NASDAQ: OREX ) will have help from Takeda once its obesity drug, Contrave, is approved.
- [By Ben Levisohn]
Vivus (VVUS) has gained 4.3% to $10.63 after Cowen upgraded it to Outperform from Hold, and Orexigen Therapeutics (OREX) rose 4% to $6.30 after Cowen started it as Outperform.
No comments:
Post a Comment